“…5 Subsequently, our testing on HeLa, OVCAR-3, and MCF-7 cells unveiled that the co-immobilization of TNF-a (tumor necrosis factor-a)/ IFN-g (interferon-g) biomaterials (based on polystyrene, polyurethane, polylactic acid copolymers) have potential for treating some types of carcinomas for women by alternate cancer cell death mechanisms. [6][7][8][9][10][11][12] Moreover, nanoparticle drugs and associated treatment technologies have been receiving widespread attention. [13][14][15][16] Among the targeting nanometer drugs, magnetic nanoparticles (MNPs, including r2-Fe 2 O 3 , Me-Fe 2 O 3 , Fe 3 O 4 , NiCo-Fe, FeCo and NiFe alloy) covered with effective anti-tumor molecules, the so-called magnetic nanoparticle drugs, offer physical therapy advantages over others, such as small particle size, large specific surface, high capacity coupling, and magnetic response, which allow possibilities to overcome the drawbacks of traditional administrations.…”